Enovix Corp
For the period ended Apr 5, 2026. Filed May 14, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Apr 5, 2026 · Filed May 14, 2026
ENVX$2.64-5.0%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Balance Sheets as of
CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands, except share and par value amounts)
| As of April 5,2026 | As of December 28,2025 | |
|---|---|---|
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $88,751 | $106,014 |
| Short-term investments | 439,985 | 406,026 |
| Accounts receivable, net | 3,943 | 4,421 |
| Notes receivable, net | — | 4,012 |
| Inventory | 16,451 | 13,617 |
| Prepaid expenses and other current assets | 9,366 | 8,120 |
| Total current assets | 558,496 | 542,210 |
| Property and equipment, net | 164,952 | 170,263 |
| Long-term investments | 52,104 | 106,810 |
| Customer relationship intangibles and other intangibles, net | 30,357 | 31,638 |
| Operating lease, right-of-use assets | 11,613 | 11,682 |
| Goodwill | 12,217 | 12,217 |
| Other assets, non-current | 4,154 | 4,155 |
| Total assets | $833,893 | $878,975 |
| Liabilities and Equity | ||
| Current liabilities: | ||
| Accounts payable | $14,938 | $17,818 |
| Accrued expenses | 8,761 | 13,992 |
| Accrued compensation | 7,631 | 6,219 |
| Short-term debt | 9,436 | 9,865 |
| Deferred revenue | 4,279 | 5,015 |
| Warrant liability | 181 | 6,578 |
| Other liabilities | 5,668 | 5,529 |
| Total current liabilities | 50,894 | 65,016 |
| Long-term debt, net | 520,160 | 519,271 |
| Operating lease liabilities, non-current | 10,906 | 11,244 |
| Deferred revenue, non-current | 300 | 300 |
| Deferred tax liability | 8,889 | 9,119 |
| Other liabilities, non-current | 14 | 14 |
| Total liabilities | 591,163 | 604,964 |
| Commitments and Contingencies (Note 7) | ||
| Stockholders’ equity: | ||
| Common stock, $0.0001 par value; authorized shares of 1,000,000,000; issued and outstanding shares of 217,698,339 and 216,556,238 as of April 5, 2026 and December 28, 2025, respectively | 22 | 22 |
| Additional paid-in-capital | 1,316,363 | 1,307,912 |
| Treasury stock, at cost | (58,385) | (58,385) |
| Accumulated other comprehensive loss | (1,241) | (508) |
| Accumulated deficit | (1,016,087) | (977,827) |
| Total Enovix's stockholders’ equity | 240,672 | 271,214 |
| Non-controlling interest | 2,058 | 2,797 |
| Total equity | 242,730 | 274,011 |
| Total liabilities and equity | $833,893 | $878,975 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.